BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Bleomycin, rs7903146, PPARA, G-protein-coupled receptor binding, Hepatitis, Heart)
Bookmark Forward

QuickView for tocilizumab (compound)


Genetic Markers

Most Correlated Genes

  1. CXCL13
  2. FCGR1A
  3. C15orf48
  4. CCL18
  5. UBD
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. FAN_OVARY_CL13_MONOCYTE_MACROPHAGE
  2. immune response
  3. MCLACHLAN_DENTAL_CARIES_UP
  4. MODULE_84
  5. TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Synovial biopsies of rheumatoid arthritis patients treated with rituximab or tocilizumab
  2. Blood of infliximab/methotrexate/tocilizumab-treated + immune cells of rheumatoid arthritis patients
  3. PBMCs and neutrophils from systemic juvenile idiopathic arthritis patients treated with tocilizumab
  4. Knee synovial biopsies from rheumatoid arthritis patients treated with tocilizumab or methotrexate
  5. Tocilizumab (anti-IL6) treatment in rheumatoid arthritis
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Efficiency and Safety of Tocilizumab for the Treatment of Thyroid Eye Disease: A Systematic Review.
  2. Intravenous versus subcutaneous tocilizumab in Takayasu arteritis: multicentre retrospective study.
  3. Tocilizumab for the treatment of COVID-19.
  4. Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19.
  5. Subcutaneous Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Tocilizumab in Cardiac Transplantation
  2. Tocilizumab for Acute Chest Syndrome
  3. Tocilizumab in Children With ACP
  4. Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)
  5. Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.